Xcout Intel
Vima Therapeutics
Vima Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. The firm pioneers treatments for dystonia and related movement disorders, focusing on novel oral therapies. It develops specialized therapeutics designed to help patients regain mobility and freedom of movement.
Subscribe to see Vima Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Vima Therapeutics at a glance
Vima Therapeutics is a drug discovery company headquartered in United States. It has raised at least $100M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $40M in March 2026. Xcout tracks 15 named people at Vima Therapeutics, including Judy Dunn (President of Research & Development).
Vima Therapeutics leadership
- Judy DunnPresident of Research & Development
- Jessica FeesChief Financial Officer
- Tushar MisraChief Technical Officer
- Ariel D. JasieChief Business Officer and General Counsel
- David GrayzelChair
- Bernard RavinaFounder and Chief Executive Officer Board Member
9 more named people on record for Vima Therapeutics, with roles, board committees and tenure — see the full roster →
Vima Therapeutics funding rounds
At least $100M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $40M | 4 named | |
| Series A | $60M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Vima Therapeutics competitors
A few of Vima Therapeutics's closest competitors — see the full list of competitors and alternatives →
Courage Therapeutics, Inc. is a for-profit biotechnology company founded in 2019 and headquartered in Newton, Massachusetts. The company operates in the biotech sector with a focus on developing therapeutic solutions.
Tortugas Neuroscience is a drug discovery and biopharmaceutical company headquartered in Framingham, Massachusetts. The company focuses on advancing innovative neuroscience therapeutics.
Diagonal Therapeutics is a biotechnology company headquartered in Watertown, Massachusetts, pioneering disease-modifying clustering antibody therapeutics to target the root causes of devastating diseases.
Astria Therapeutics, Inc. is a public biopharmaceutical company headquartered in Boston, Massachusetts, dedicated to developing life-changing therapies for patients.
Caldera Therapeutics, Inc. is a Cambridge, Massachusetts-based clinical-stage biotechnology company focused on treatments such as a bispecific inflammatory bowel disease (IBD) asset.
AIRNA Corp is a biotechnology company headquartered in Cambridge, Massachusetts, focused on developing RNA editing therapeutics. Its leading program utilizes ADAR-recruiting technology to target specific RNA locations for therapeutic applications.
Get Vima Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Vima Therapeutics in Xcout Intel
- 15 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access